IN CASE YOU MISSED THEM, HERE ARE 2 EMAIL RESPONSES TO KLEE FROM CEO,CFO IN LAST WEEK OR SO...
Thought I would share the CFO's response to an email I sent while we wait for our REVS and the VW Contract as well as the name change. Enjoy...
CNUV
Quote:
________________________________________
<my name>
Please let me introduce myself, Barry Hollander, CFO of China Nuvo Solar Energy, Inc. I have been the CFO since 2002 and I am continuing as CFO post transaction with SurgLine.
You seem like a sophisticated investor and therefore I am sure you appreciate the fact that as a public company we can not discuss items individually with you that we have not made public. I am sure the last thing you want is to be trading our stock on "insider information". That being said I can address some of your issues that are in the public domain as well as our Corporate objectives and goals.
Please note that Mr. Toland had been added to our Board of Directors , and based on his career experience in the healthcare industry has also been named CEO. Mr. Fong, is still a member of our Board of Directors, and we as a team value his experience with public companys. I have worked with Mr. Fong for 20 years.
The shares that were issued in the transaction between SurgLine and China Nuvo were restricted shares, therefore please rest assured that NONE of the these new shareholders, including any NEW officers and directors of the company are "dumping shares into the market."
We cannot control the day to day trading activity in our stock . what we can control and our determined with a single focus, as Mr. Toland stated in his earlier response to you, is to bring value to all shareholders through the execution of our business plan and model. We are well aware of our filing requirements including appropriate disclosures and will follow those rules and regulations regarding reporting of revenues and any potential acquisitions.
We appreciate your support
Best regards,
Barry Hollander, CFO
I wrote to Mr. Toland today. His response took exactly 20-minutes, and I have to say I am most pleased with his response.
----------------------------------------------------------------
(my name), thank you for your email .
Our top prioity is shareholder value. Surgline's merger was completed approximately 30 days ago, and our managment team is focused on building long-term shareholder value.
Although Mr. Fong is no longer the CEO, and I have assumed the roll as CEO of SurgLine, we are extremely focused on delivering shareholder value over the long-term. We will do that by staying focused on acute care opportunities in the healthcare sector and more specificaly, the medical device sector.
I appreciate fully your concerns as the CEO of SurgLine and will communicate them to my team.
We look forward to reporting exceptional success in executing our business plan, both top line revenues and earnings as we continue to execute our strategy in the future. And although I and for that matter our SurgLine team had no involvement in the FREYA transaction, shareholder value is our #1 priority.
Thank you again for your email.
Thomas G Toland
CEO
Surgline, Inc.
"More Value for your healthcare dollar"
Market Data 
Markets 
AI
